IL33 in rheumatoid arthritis: potential contribution to pathogenesis
Rev. bras. reumatol; 56 (5), 2016
ABSTRACT A better understanding of the inflammatory mechanisms of rheumatoid arthritis and the development of biological therapy revolutionized its treatment, enabling an interference in the synovitis – structural damage – functional disability cycle. Interleukin 33 was recently described as ...